Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation
source: pixabay.com

Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation

According to a story from BioSpace, the biotechnology company Ascentage Pharma has just announced that it has been given Orphan Drug designation from the US Food and Drug Administration (FDA).…

Continue Reading Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation
Study Aims to Discover How COVID-19 is Affecting WM Patients
source: pixabay.com

Study Aims to Discover How COVID-19 is Affecting WM Patients

A new study is seeking to understand how the ongoing coronavirus/COVID-19 pandemic is impacting patients with a rare blood cancer called Waldenström's macroglobulinemia (WM). The research is to be conducted…

Continue Reading Study Aims to Discover How COVID-19 is Affecting WM Patients

The IWMF and CancerCare’s “For Caregivers: Coping with a Loved One’s WM” Workshop

The International Waldenstrom's Macroglobulinemia Foundation and CancerCare's Connect Education Workshop: "For Caregivers: Coping with a Loved One's WM" January 10th, 2020 from 1:30-2:30 pm This workshop will be geared towards…

Continue Reading The IWMF and CancerCare’s “For Caregivers: Coping with a Loved One’s WM” Workshop
IWMF and PleXus Communications are Teaming up to Help Spread Waldenstrom’s Macroglobulinemia Awareness
Nappiness / Pixabay

IWMF and PleXus Communications are Teaming up to Help Spread Waldenstrom’s Macroglobulinemia Awareness

The International Waldenstrom's Macroglobulinemia Foundation (IWMF) has recently announced an exciting new partnership that will help facilitate spreading awareness about Waldenstrom's macroglobulinemia (WM), a rare form of blood cancer. This…

Continue Reading IWMF and PleXus Communications are Teaming up to Help Spread Waldenstrom’s Macroglobulinemia Awareness

Waldenstrom’s Macroglobulinemia: A Rare Patient Story

On the weekend of June 7th through 9th, I had the privilege of attending the 2019 International Waldenstrom's Macroglobulinemia Foundation's Annual Educational Forum in Philadelphia, Pennsylvania on the behalf of…

Continue Reading Waldenstrom’s Macroglobulinemia: A Rare Patient Story
Research Updates for Multiple Myeloma and WM!
Source: Pixabay.com

Research Updates for Multiple Myeloma and WM!

Dana-Farber Cancer Institute has just announced research updates on multiple myeloma and waldenstrom macroglobulinemia which indicate significant progress in the search for treatments for these diseases. The Findings 1) There…

Continue Reading Research Updates for Multiple Myeloma and WM!

2018 International Waldenstrom’s Macroglobulinemia Foundation Events You Don’t Want to Miss

After the 10th International Workshop on Waldenstrom’s Macroglobulinemia for researchers and clinicians, the IWWM10 International Doctor- Patient Forum will be held in the same place on the same day. If…

Continue Reading 2018 International Waldenstrom’s Macroglobulinemia Foundation Events You Don’t Want to Miss
Staying In-The-Know with Waldenstrom Macroglobulinemia Treatment
Source: pixabay.com

Staying In-The-Know with Waldenstrom Macroglobulinemia Treatment

Although there are treatments currently available with a proven track record against rare types of cancers, such as Waldenstrom macroglobulinemia, with any treatment, however successful, there will be a handful…

Continue Reading Staying In-The-Know with Waldenstrom Macroglobulinemia Treatment
Close Menu